Bone Marrow TransplantationTransplantation, AutologousBone MarrowTransplantation, HomologousBone Marrow CellsBone Marrow PurgingWhole-Body IrradiationGraft vs Host DiseaseCombined Modality TherapyCyclophosphamideLymphoma, Non-HodgkinCarmustineHematopoietic Stem Cell TransplantationTransplantation ConditioningBusulfanLeukemiaBone and BonesMelphalanRemission InductionAnemia, AplasticAntineoplastic Combined Chemotherapy ProtocolsLeukemia, Myeloid, AcuteGraft SurvivalHematopoietic Stem CellsRecurrenceEtoposideHodgkin DiseaseLiver TransplantationTransplantation ChimeraBone Marrow DiseasesCytarabineHematopoiesisTissue DonorsTreatment OutcomeLeukemia, MyeloidPrecursor Cell Lymphoblastic Leukemia-LymphomaColony-Forming Units AssayActuarial AnalysisHistocompatibility TestingTransplantation, IsogeneicHistocompatibilitySurvival AnalysisTime FactorsKidney TransplantationAcute DiseaseLymphomaVincristinePodophyllotoxinStem Cell TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic NeoplasmsDrug EvaluationMice, Inbred C57BLFollow-Up StudiesHepatic Veno-Occlusive DiseaseDisease-Free SurvivalSurvival RateRadiation ChimeraSalvage TherapyImmunosuppressionImmunosuppressive AgentsBone Marrow ExaminationLeukocyte CountMyelodysplastic SyndromesRetrospective StudiesGraft RejectionGranulocyte Colony-Stimulating FactorThiotepaT-LymphocytesBone RemodelingBone Marrow NeoplasmsCyclosporineTransplantation ImmunologyMultiple MyelomaHematologic DiseasesGraft vs Host ReactionPrognosisLymphocyte DepletionLeukocyte TransfusionHeart TransplantationGranulocytesPrednisoneAntibodies, MonoclonalPlatelet CountSevere Combined ImmunodeficiencyGranulocyte-Macrophage Colony-Stimulating FactorHLA AntigensBlood Cell CountChimeraProspective StudiesLymphatic IrradiationMitoxantroneLung TransplantationNeuroblastomaGonadal DisordersCell SeparationLymphocyte TransfusionBone DensityDoxorubicinCell Differentiation